EE+ POEM Archive
GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "GLP-1 Agonists Associated With Lower Stroke Risk in Patients With Type 2 Diabetes at High Risk for Cardiovascular Disease." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315036/all/GLP_1_agonists_associated_with_lower_stroke_risk_in_patients_with_type_2_diabetes_at_high_risk_for_cardiovascular_disease.
GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315036/all/GLP_1_agonists_associated_with_lower_stroke_risk_in_patients_with_type_2_diabetes_at_high_risk_for_cardiovascular_disease. Accessed October 5, 2024.
GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315036/all/GLP_1_agonists_associated_with_lower_stroke_risk_in_patients_with_type_2_diabetes_at_high_risk_for_cardiovascular_disease
GLP-1 Agonists Associated With Lower Stroke Risk in Patients With Type 2 Diabetes at High Risk for Cardiovascular Disease [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315036/all/GLP_1_agonists_associated_with_lower_stroke_risk_in_patients_with_type_2_diabetes_at_high_risk_for_cardiovascular_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GLP-1 agonists associated with lower stroke risk in patients with type 2 diabetes at high risk for cardiovascular disease
ID - 1315036
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315036/all/GLP_1_agonists_associated_with_lower_stroke_risk_in_patients_with_type_2_diabetes_at_high_risk_for_cardiovascular_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
